Skip to content

Clinical trials

Completed Multiple Myeloma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Status: Completed Country / region: China Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20124
20131
20152
20165
20173
20183
20198
20205
20214
20227
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC5
Celgene3
Pfizer3
Takeda3
Amgen2
Antengene Corporation2
Sanofi2
Shanghai Changzheng Hospital2
TJ Biopharma Co., Ltd.2
3D Medicines1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma47
Recurrence7
Lymphoma, Non-Hodgkin3
Neoplasms3
Neoplasms, Plasma Cell3
Lymphoma2
Myelodysplastic Syndromes2
Amyloidosis1
Blood Protein Disorders1
Cancer Pain1

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.